用放射治疗控制的前列腺SMARCB1缺陷基底细胞癌
Shunta Makabe1, Tomoyuki Koguchi1, Kanako Matsuoka1
1Department of Urology Fukushima Medical University School of Medicine Fukushima Japan.
IJU case reports
|July 5, 2023
概括
放射治疗有效控制了复发和转移的罕见前列腺基础细胞癌. 基因组分析确定了SMARCB1删除是疾病进展的潜在预后因素.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 前列腺的基底细胞癌 (BCC) 是一种非常罕见的恶性瘤.
- 对于复发性或转移性前列腺BCC缺乏既定的治疗方案.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K